ROSUVASTATINE Sandoz cpr pell 20 mg 50 pce

7680664140200 CH-66414 C10AA07 07.12.0.

Reimbursement limitations:

ROSUVASTSand

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ROSUVASTATINE Sandoz cpr pell 20 mg 50 pce
ROSUVASTATINE Sandoz cpr pell 20 mg 50 pce
1 / 2
google

Details

Product number
6641403
CPT
-
Packaging group
50
Unit
Tablette(n)
Composition
Filmtablette: rosuvastatinum 20 mg ut rosuvastatinum calcicum, lactosum 105.84 mg, silica colloidalis anhydrica, cellulosum microcristallinum silicificatum, maydis amylum, talcum, natrii stearylis fumaras corresp. natrium 0.19 mg, Überzug: hypromellosum, mannitolum, macrogolum 6000, E 171, E 172 (flavum), E 172 (rubrum), talcum, pro compresso obducto.

Articles (1)

Rosuvastatin Sandoz 20 mg, Filmtabletten
Filmtabletten
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/05/2024
Patient information leaflet
Français
03/05/2024
Patient information leaflet
Italien
03/05/2024
Professional SmPC
Allemand
03/05/2024
Professional SmPC
Français
03/05/2024
Professional SmPC
Italien
03/05/2024

Detailed composition

Substance Quantity Type Category
FTAB
20.0 MG Substance Wirkstoff (Principe actif)
FTAB
- Substance WIZUS
FTAB
105.84 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
0.19 MG Substance HBESI
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK
FTAB
- Substance FTODK
FTAB
- Substance FTODK
FTAB
- Substance HNIDK

Reimbursement information

Public price
CHF 37.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2020

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
66414
Drug name
Rosuvastatin Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
08/02/2017
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen

Packaging details

Description (FR)
ROSUVASTATINE Sandoz cpr pell 20 mg 50 pce
Description (DE)
ROSUVASTATIN Sandoz Filmtabl 20 mg 50 Stk
Market launch
08/02/2017
Narcotic (BTM)
No

Original drug

Crestor, Filmtabletten
CHF 29.50
View original

Other packaging sizes

ROSUVASTATINE Sandoz cpr pell 5 mg 30 pce
30 TABL
View
ROSUVASTATINE Sandoz cpr pell 5 mg 50 pce
50 TABL
View
ROSUVASTATINE Sandoz cpr pell 5 mg 100 pce
100 TABL
View
ROSUVASTATINE Sandoz cpr pell 10 mg 30 pce
30 TABL
View